Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods have a higher risk of heart disease.

People with alopecia areata have a higher risk of heart disease.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Understanding genetics is crucial for treating heart and skin diseases.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Anabolic-androgenic steroids increase the risk of heart problems.

Minoxidil can cause life-threatening heart complications, so careful monitoring is essential.

Some blood pressure medications are linked to a higher risk of skin cancer.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Hemodialysis patients often experience skin issues like dryness and itching, linked to certain blood chemical levels.

A potential genetic link between Werner syndrome and kidney disease was suggested.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Oral minoxidil users, especially for hypertension, may risk heart issues, and better monitoring guidelines are needed for alopecia patients.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Women with PCOS have higher cardiometabolic risks, but these may be reduced.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.